logo

Immunic, Inc (IMUX)



Trade IMUX now with
  Date
  Headline
11/17/2020 6:39:21 AM Immunic Announces Formation Of A Scientific-Medical Advisory Board
11/2/2020 6:41:37 AM Immunic Says 200 Patients Enrolled In Phase 2 CALVID-1 Trial Of IMU-838; Expects Top-Line Data In Q1 2021
9/28/2020 6:35:58 AM Immunic Announces Results From Interim Safety Analysis And Recruitment Update From Phase 2 CALVID-1 Trial Of IMU-838
9/11/2020 6:34:37 AM Immunic Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial Of IMU-838
8/20/2020 6:32:19 AM Immunic Announces Dosing Of First Healthy Volunteer In Phase 1 Clinical Program Of IMU-856
8/10/2020 6:35:50 AM Immunic Announces Closing Of Public Offering Of 5.75 Mln Shares At $18/Shr
8/4/2020 8:44:46 PM Immunic Prices Public Offering Of 5 Mln Shares At $18.00/shr
7/27/2020 6:42:31 AM Immunic Enrolls First Patients In Phase 2 Clinical Trial Of Selective Oral DHODH Inhibitor, IMU-838
6/15/2020 6:31:53 AM Immunic Announces First Patients Dosed In Phase 2, CALVID-1 Clinical Trial Of IMU-838 In COVID-19
6/10/2020 9:20:05 AM Immunic Prices $25 Mln Public Offering Of Common Stock